Treatment of dyslipidaemia with fluvavastin in patients with type 2 diabetes mellitus. Effects on lipids, mental state and fibrinolysis.

F.L.J. Visseren; K.P. Bouter; B.J. Potter-van Loon; D.W. Erkelens

Treatment of dyslipidaemia with fluvavastin in patients with type 2 diabetes mellitus. Effects on lipids, mental state and fibrinolysis.

Translated title of the contribution: Treatment of dyslipidaemia with fluvavastin in patients with type 2 diabetes mellitus. Effects on lipids, mental state and fibrinolysis.

F.L.J. Visseren
, K.P. Bouter
, B.J. Potter-van Loon
, D.W. Erkelens

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Treatment of dyslipidaemia with fluvavastin in patients with type 2 diabetes mellitus. Effects on lipids, mental state and fibrinolysis.
Original language	Undefined/Unknown
Pages (from-to)	671-678
Number of pages	8
Journal	Clinical Drug Investigation
Volume	21
Publication status	Published - 2001

Cite this

@article{733b38da11e747e59ebfc8a250cf24c1,

title = "Treatment of dyslipidaemia with fluvavastin in patients with type 2 diabetes mellitus. Effects on lipids, mental state and fibrinolysis.",

author = "F.L.J. Visseren and K.P. Bouter and \{Potter-van Loon\}, B.J. and D.W. Erkelens",

year = "2001",

language = "Undefined/Unknown",

volume = "21",

pages = "671--678",

journal = "Clinical Drug Investigation",

issn = "1173-2563",

publisher = "Adis",

}

TY - JOUR

T1 - Treatment of dyslipidaemia with fluvavastin in patients with type 2 diabetes mellitus. Effects on lipids, mental state and fibrinolysis.

AU - Visseren, F.L.J.

AU - Bouter, K.P.

AU - Potter-van Loon, B.J.

AU - Erkelens, D.W.

PY - 2001

Y1 - 2001

M3 - Article

SN - 1173-2563

VL - 21

SP - 671

EP - 678

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

ER -